At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avid's pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages of pathological change; allowing early treatment and management of people at risk - perhaps before before symptoms of disease can develop.

Health Care

Life Sciences

Therapeutics

Avid Radiopharmaceuticals

Ian Halvorsen

David Wilson

Lisaann Trembath

Kelly Conway

Amanda Morris

Marybeth Devine

Caitlin Pearson

Christine Gallagher

Luckens Osias

Anne McGeehan

Carey Horchler

Robert Morrison

The Operations and Support team at Avid Radiopharmaceuticals plays a crucial role in ensuring the efficient execution of business operations and technical processes essential for developing molecular imaging agents. This team oversees financial management, supply chain logistics, and clinical operations support, facilitating collaborative efforts across departments to bring innovative imaging solutions to market. Their strategic initiatives help streamline workflows, optimize resource utilization, and uphold compliance with industry standards, ultimately contributing to the company's mission of early disease detection and improved patient management.

Operations and Support

Research and Development

Clinical Operations and Management

Operations and Support

About

Team members

Other teams at Avid Radiopharmaceuticals

Research and Development

Clinical Operations and Management